Does CAPLACIZUMAB-YHDP Cause Unevaluable event? 16 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Unevaluable event have been filed in association with CAPLACIZUMAB-YHDP. This represents 1.2% of all adverse event reports for CAPLACIZUMAB-YHDP.
16
Reports of Unevaluable event with CAPLACIZUMAB-YHDP
1.2%
of all CAPLACIZUMAB-YHDP reports
1
Deaths
1
Hospitalizations
How Dangerous Is Unevaluable event From CAPLACIZUMAB-YHDP?
Of the 16 reports, 1 (6.3%) resulted in death, 1 (6.3%) required hospitalization, and 1 (6.3%) were considered life-threatening.
Is Unevaluable event Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CAPLACIZUMAB-YHDP. However, 16 reports have been filed with the FAERS database.
What Other Side Effects Does CAPLACIZUMAB-YHDP Cause?
Product use in unapproved indication (465)
Adamts13 activity decreased (136)
Off label use (133)
Platelet count decreased (126)
Epistaxis (123)
Fatigue (110)
Contusion (86)
Injection site pain (74)
Headache (71)
Adamts13 activity abnormal (63)
What Other Drugs Cause Unevaluable event?
ADALIMUMAB (4,242)
ETANERCEPT (3,902)
LENALIDOMIDE (3,331)
OXYCODONE (3,145)
AMBRISENTAN (2,336)
SODIUM OXYBATE (2,328)
CARBIDOPA\LEVODOPA (1,632)
DUPILUMAB (1,410)
MORPHINE (1,161)
ACETAMINOPHEN\HYDROCODONE (1,118)
Which CAPLACIZUMAB-YHDP Alternatives Have Lower Unevaluable event Risk?
CAPLACIZUMAB-YHDP vs CAPMATINIB
CAPLACIZUMAB-YHDP vs CAPREOMYCIN
CAPLACIZUMAB-YHDP vs CAPSAICIN
CAPLACIZUMAB-YHDP vs CAPTOPRIL
CAPLACIZUMAB-YHDP vs CARBAMAZEPINE